Measuring Gene Expression via mRNA Abundance in Candida auris

Methods Mol Biol. 2022:2517:155-164. doi: 10.1007/978-1-0716-2417-3_11.

Abstract

The recently emerged human pathogenic yeast Candida auris has become a major global threat. As compared to other Candida species, C. auris often displays a high level of resistance to commonly used antifungals and poses additional therapeutic challenges. There is a great need to understand the molecular basis of its success as a drug-resistant human pathogen. The study of condition-specific gene expression can provide good cues of regulatory circuitry governing high drug resistance. Here, we describe the protocol of quantitative reverse transcription PCR (RT-qPCR) which can be conveniently employed as a highly reproducible method for measuring individual transcripts in C. auris cells.

Keywords: Candida auris; Drug resistance; Polymerase chain reaction; Quantitative reverse transcription; RNA; Transcriptome.

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Candida / genetics
  • Candida auris
  • Candidiasis* / drug therapy
  • Gene Expression
  • Humans
  • Microbial Sensitivity Tests
  • RNA, Messenger / genetics
  • RNA, Messenger / therapeutic use

Substances

  • Antifungal Agents
  • RNA, Messenger